AviadoBio
Latest round
- Series A
Last raised
- Dec 2021
Total raised
- $93M
Investors
- 8
About AviadoBio
Based in London, UK, and founded in 2019 by Chris Shaw, Youn Bok Lee, and Do Young Lee, AviadoBio Limited is a developer of transformative gene therapies for patients with neurodegenerative disorders. AviadoBio Limited provides transformative gene therapies for patients with life-threatening neurodegenerative disorders, such as amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) through the potential of gene therapy.
Who invested in AviadoBio
8 investors across 2 rounds
See all investors in AviadoBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about AviadoBio
Who invested in AviadoBio?
AviadoBio has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has AviadoBio raised?
AviadoBio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did AviadoBio last raise money?
AviadoBio's most recent round on record is a Series A, in Dec 2021.
What does AviadoBio do?
Based in London, UK, and founded in 2019 by Chris Shaw, Youn Bok Lee, and Do Young Lee, AviadoBio Limited is a developer of transformative gene therapies for patients with neurodegenerative disorders.
Where is AviadoBio headquartered?
AviadoBio is headquartered in London, UK.
Which VCs invest in companies like AviadoBio?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at AviadoBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like AviadoBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.